Our Promise

Product Innovation Advancing
Patient Care with Excellence

Our Mission

To leverage internal expertise and external relationships to rapidly deliver high quality, low cost, high margin medical devices to the orthopedic market with a value proposition that is the right balance for the surgeon, hospital administration, OR staff, distributor, and patient.

Core Principles

  • World-class scalable manufacturing
  • Lean operational discipline and superior quality
  • Accelerated R&D pipeline
  • Novel intellectual property
  • Inspire to be the industry leader

About Curiteva

Curiteva is a privately held technology and manufacturing company based in Huntsville, AL. The company was founded in 2017 in a 35,000 sq ft facility by a machinist entrepreneur, focusing on building a portfolio of proprietary spinal implants. Since its founding, Curiteva is pioneering 3D printing of porous PEEK implants with a bioactive nano-surface to revolutionize how engineered structures and implant biomaterials accelerate immunomodulation, enhance healing, and improve patient outcomes.


Curiteva’s leadership team and their unwavering commitment to product and process excellence is foundational to success.


Mike English

Founder and CTO

Eric Linder


Phil Cupero


Bill Voss

Executive Vice President

Mark Mohlman

Chief Scientific Officer

Erik Erbe, PhD

In the News

Curiteva Featured In Additive Manufacturing Media

Curiteva uses a novel 3D printing method called fused strand deposition (FSD), that is designed, programmed and built by the company. The company achieved FDA approval and is now in production for its first 3D printed PEEK implant, the cervical spine cage featured in this episode.

Read Article

Curiteva Announces World’s First 3D Printed PEEK Device With Regulatory Clearance Reaches Full Commercial Launch in the United States

Curiteva, a privately held technology and manufacturing company based in Huntsville, AL announces the commercial launch of its Inspire Porous PEEK HAFUSE Cervical Interbody System.

Read Article

Curiteva Strengthens Inspire® Patent Portfolio with New Patent Issued for the Novel 3D Printed Porous PEEK with HAFUSE™ Technology

Huntsville, AL based technology company Curiteva is pleased to announce the expansion of its patent portfolio with the issuance of the third Utility Patent in support of their novel Inspire 3D printed porous PEEK with HAFUSE technology. This marks the 16th issued patent for Curiteva strengthening their position as a market leader in the 3D printing of porous PEEK.

Read Article

First Surgeries Performed with Novel 3D Printed Porous PEEK HAFUSE Technology

Curiteva announced a limited commercial release utilizing its recently FDA-cleared Inspire Porous PEEK HAFUSE Cervical Interbody System. Curiteva pioneered and received clearance of the world’s first 3D printed, fully interconnected porous PEEK structure, utilizing internally developed Fused Filament Fabrication.

Read Article

3D-Printed Porous PEEK Pioneers Reach Spine Market

BONEZONE reports that Curiteva received FDA 510(k) clearance for Inspire Porous PEEK. The cervical interbody system is manufactured through a proprietary and patented Fused Filament Fabrication (FFF) 3D printer that is designed, programmed and built by Todd Reith.

Read Article

FDA Clears Truly Novel 3D Printed Peek Spinal Implant

Orthopedics This Week reports on the U.S. Food and Drug Administration (FDA) granting 510(k) clearance to a truly novel 3D printed PEEK implant.

Read Article

Curiteva Inc. Announces FDA 510(k) Clearance for Inspire™ 3D Porous PEEK HAFUSE™ Cervical Interbody System

Curiteva announces the first FDA 510(k) cleared 3D printed PEEK implant, the Inspire Porous PEEK Cervical Interbody System with HAFUSE Technology.

Read Article

Curiteva Announces Six Consecutive Quarters of Growth and the Launch of Several New Products

Curiteva, Inc announced record revenue for Q3 2020 with the successful launch of their Prodigy Open and MIS posterior fixation systems.

Read Article

Curiteva Adds Steve Cichy as Strategic Advisor and Erik Erbe, PhD, as Vice President of Clinical and Research

Curiteva, Inc. announced today the addition of Steve Cichy as a Strategic Advisor to the rapidly growing technology company.

Read Article

Curiteva, Inc. Acquires FossiLabs, LLC: Redefines Active Implant

Curiteva announced a market-shifting transaction with the acquisition of FossiLabs, a company focused on the development of Fused Filament Fabrication 3D printed PEEK medical implants.

Read Article